EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour

Mina S Farag iD, Neda Oghbaei, Jaffar Hussain iD, André Lametti iD, Wassim Kassouf iD, Fadi Brimo iD

Histopathology · 2026-06 · 88 (7) · 1430-1442

DOI: 10.1111/his.70086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, online erschienen am 28.12.2025. Verfasst von Mina S Farag und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Papillary, Carcinoma, Transitional Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The latest WHO edition proposed using a cut‐off of ≥5% high‐grade component (%HGc) as a criterion to label non‐invasive papillary urothelial carcinomas as high‐grade (pTaHG). It also suggested that tumours with minor high‐grade component behave more indolently and are better labelled as mixed low‐ and high‐grade papillary carcinomas. Methods and Results We investigated the prognostic value of %HGc along with other clinical and morphological parameters. 130 pTaHGs and 96 pTaLGs were included. 9% and 12% of pTaHGs had ≤5% and ≤10% HGc, respectively. Anaplasia was present in six cases (5%), necrosis in 18 cases (14%) and CIS in 5 cases (4%). On average, the highest mitotic count per 1 HPF was 2.4 (range = 0–18), and the mean number of mitoses per 10 HPF was 9 (range: 0–93). The mean tumour diameter was 2.1 cm. Tumour multifocality was observed in 32 cases (25%). Among the histological parameters, only mitotic activity showed a correlation with the %HGc ( P < 0.001). While recurrence was not significantly different between pTaLGs and pTaHGs (25% vs 35%; P = 0.09), stage progression was significantly different (0% vs 8%; P = 0.005). The two parameters that were associated with recurrence in pTaHGs were tumour multifocality and BCG therapy, while none was associated with progression. %HGc ≤5% and ≤ 10% did not correlate with lower rates of recurrence nor progression.

Conclusions

Those findings suggest that pTaHGs with minor HGc do not exhibit more indolent behaviour and should not be approached similar to pTaLGs. [Correction added on 13 April 2026, after first online publication: This version changes the preceding sentence from “should be approached” to “should not be approached”.]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, PapillaryCarcinoma, Transitional CellHumansMaleFemaleAgedMiddle AgedNeoplasm GradingAged, 80 and overPrognosisAdult

Stichwörter der Autor:innen

grademinormixedpapillaryprognosisurothelial

Autor:innen und Institutionen

  • Department of Pathology, McGill University, Montreal, Quebec, Canada.
  • Research Institute, McGill University, Montreal, Quebec, Canada.
  • Department of Urology, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Mina S Farag, Jaffar Hussain, André Lametti, Wassim Kassouf, Fadi Brimo

Zitieren

APA

Farag, M. S., Oghbaei, N., Hussain, J., Lametti, A., Kassouf, W., & Brimo, F. (2026). A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour. Histopathology, 88(7), 1430-1442. https://doi.org/10.1111/his.70086

Vancouver

Farag MS, Oghbaei N, Hussain J, Lametti A, Kassouf W, Brimo F. A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour. Histopathology. 2026;88(7):1430-1442. doi:10.1111/his.70086

BibTeX
@article{Farag2026,
  author = {Farag, Mina S and Oghbaei, Neda and Hussain, Jaffar and Lametti, André and Kassouf, Wassim and Brimo, Fadi},
  title = {A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour},
  journal = {Histopathology},
  year = {2026},
  volume = {88},
  number = {7},
  pages = {1430--1442},
  doi = {10.1111/his.70086}
}
Kostenlos starten →